H. pylori seroprevalence and risk of diabetes: an ancillary case–control study nested in the Diabetes Prevention Program

Publication Description
Abstract Objective To determine the association between H. pylori infection and risk of incident diabetes in adults at high risk for diabetes who participated in the Diabetes Prevention Program (DPP) study. Methods In a nested case–control study conducted among 421 adults with newly diagnosed diabetes and 421 matched controls, we examined the association between serological status of H. pylori at baseline and risk of incident diabetes over a mean follow-up period of 2.6 years. Using data from the baseline visit of the DPP, we also examined the cross-sectional association between presence of H. pylori antibodies and insulin sensitivity, insulin secretion and the disposition index-like measure after a 75-gram oral glucose tolerance test (OGTT). Results At baseline, H. pylori antibodies were present in 40% of participants who developed diabetes and 39% of controls. After adjusting for matching factors, there was no association between exposure to H. pylori and incident diabetes (odds ratio [OR] of 1.04 (95% CI, 0.77 to 1.40). In cross-sectional analyses, H. pylori status was not significantly associated with insulin sensitivity and disposition index-like measure from OGTT. Conclusions In adults at high risk for diabetes, H. pylori seropositivity was not associated with risk of developing diabetes.

Primary Author
Alzahrani,Saud
Nelson,Jason
Moss,Steven F.
Paulus,Jessica K.
Knowler,William C.
Pittas,Anastassios G.

Volume
31

Issue
10

Start Page
1515

Other Pages
1520

Publisher
Elsevier Inc

URL
https://www.clinicalkey.es/playcontent/1-s2.0-S1056872717305251

PMID
28739267

PMCID
PMC5603174



Reference Type
Journal Article

Periodical Full
Journal of Diabetes and Its Complications

Publication Year
2017

Place of Publication
United States

ISSN/ISBN
1056-8727

Document Object Index
10.1016/j.jdiacomp.2017.05.015